HRMY
Harmony Biosciences Holdings Inc
1 day chart
About HRMY
Harmony Biosciences Holdings, Inc. is a holding company. The Company’s operations are conducted through its wholly owned subsidiary, Harmony Biosciences, LLC (Harmony). The Company is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients with neurological disorders. The Company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action (MOA) specifically designed to increase histamine signaling in the brain by binding to H3 receptors. WAKIX is developed for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy and is the narcolepsy treatment that works primarily through histamine, which is a neurotransmitter. The Company also provides HBS-102, an investigational compound, is a melanin-concentrating hormone (MCH) receptor 1(MCHR1) antagonist that targets MCH neurons in the brain.
Buy US stocks in Australia with $0 brokerage and trade HRMY today!
$2.58B
-
0.00%
683.7K
$44.89
$43.18
$43.77
$57.13
$31.54
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.